We	We	PRP	B-NP	O	
have	have	VBP	B-VP	O	
used	use	VBN	I-VP	O	
polycyclic	polycyclic	JJ	B-NP	O	
aromatic	aromatic	JJ	I-NP	O	
hydrocarbon	hydrocarbon	NN	I-NP	O	
(	(	(	O	O	
PAH	PAH	NN	B-NP	O	
)	)	)	O	O	
alkyne	alkyne	VBP	B-VP	O	
metabolism-based	metabolism-based	JJ	B-NP	O	
inhibitors	inhibitor	NNS	I-NP	O	
to	to	TO	B-VP	O	
test	test	VB	I-VP	O	
whether	whether	IN	B-SBAR	O	
CYP1B1	CYP1B1	NN	B-NP	O	
metabolism	metabolism	NN	I-NP	O	
is	be	VBZ	B-VP	O	
linked	link	VBN	I-VP	O	
to	to	TO	B-PP	O	
aryl	aryl	NN	B-NP	B-protein	
hydrocarbon	hydrocarbon	NN	I-NP	I-protein	
receptor	receptor	NN	I-NP	I-protein	
(	(	(	O	O	
AhR	AhR	NN	B-NP	B-protein	
)	)	)	O	O	
activation	activation	NN	B-NP	O	
in	in	IN	B-PP	O	
mouse	mouse	NN	B-NP	B-cell_type	Mention 46	
embryo	embryo	NN	I-NP	I-cell_type	
fibroblasts	fibroblast	NNS	I-NP	I-cell_type	
(	(	(	O	O	
MEF	MEF	NN	B-NP	B-protein	
)	)	)	O	O	
.	.	.	O	O	
1-ethynylpyrene	1-ethynylpyrene	NN	B-NP	O	Mention 47	
(	(	(	O	O	
1EP	1EP	NN	B-NP	O	Mention 48	
)	)	)	O	O	
selectively	selectively	RB	B-ADVP	O	
inactivated	inactivate	VBD	B-VP	O	
CYP1B1	CYP1B1	NN	B-NP	O	
dimethylbenzanthracene	dimethylbenzanthracene	NN	I-NP	O	Mention 49	
(	(	(	O	O	
DMBA	DMBA	NN	B-NP	O	Mention 50	
)	)	)	O	O	
metabolism	metabolism	NN	B-NP	O	
in	in	IN	B-PP	O	
C3H10T1/2	C3H10T1/2	NN	B-NP	B-protein	Mention 51	
MEFs	MEF	NNS	I-NP	I-protein	
;	;	:	O	O	
whereas	whereas	IN	O	O	
1-	1-	NN	B-NP	O	Mention 52	
(	(	(	O	O	
1-propynyl	1-propynyl	NN	B-NP	O	
)	)	)	O	O	
pyrene	pyrene	NN	B-NP	O	
(	(	(	O	O	
1PP	1PP	NN	B-NP	O	Mention 53	
)	)	)	O	O	
preferentially	preferentially	RB	B-ADVP	O	
inhibited	inhibit	VBD	B-VP	O	
CYP1A1	CYP1A1	NN	B-NP	B-protein	Mention 54	
activity	activity	NN	I-NP	O	
in	in	IN	B-PP	O	
Hepa-1c1c7	Hepa-1c1c7	NN	B-NP	B-cell_line	Mention 55	
mouse	mouse	NN	I-NP	I-cell_line	
hepatoma	hepatoma	NN	I-NP	I-cell_line	
cells	cell	NNS	I-NP	I-cell_line	
(	(	(	O	O	
Hepa	Hepa	NN	B-NP	B-protein	
)	)	)	O	O	
.	.	.	O	O	
In	In	IN	B-PP	O	
each	each	DT	B-NP	O	Mention 56	
cell	cell	NN	I-NP	O	
type	type	NN	I-NP	O	
>	>	SYM	O	O	
90	90	CD	B-NP	O	
%	%	NN	I-NP	O	
inhibition	inhibition	NN	I-NP	O	
of	of	IN	B-PP	O	
DMBA	DMBA	NN	B-NP	O	Mention 57	
metabolism	metabolism	NN	I-NP	O	
after	after	IN	B-PP	O	
1	1	CD	B-NP	O	
h	h	NN	I-NP	O	
treatment	treatment	NN	I-NP	O	
with	with	IN	B-PP	O	
each	each	DT	B-NP	O	Mention 58	
inhibitor	inhibitor	NN	I-NP	O	
(	(	(	O	O	
0	0	CD	B-NP	O	
.	.	.	O	O	
1	1	CD	B-NP	O	
microM	microM	NN	I-NP	O	
)	)	)	O	O	
was	be	VBD	B-VP	O	
progressively	progressively	RB	I-VP	O	
reversed	reverse	VBN	I-VP	O	
and	and	CC	O	O	
then	then	RB	O	O	
increased	increase	VBD	B-VP	O	
to	to	TO	B-PP	O	
levels	level	NNS	B-NP	O	
seen	see	VBN	B-VP	O	
with	with	IN	B-PP	O	
2	2	CD	B-NP	O	
,	,	,	I-NP	O	
3	3	CD	I-NP	O	
,	,	,	I-NP	O	
7	7	CD	I-NP	O	
,	,	,	O	O	
8-tetrachlorodibenzo-p-dioxin	8-tetrachlorodibenzo-p-dioxin	NN	B-NP	O	
(	(	(	O	O	
TCDD	TCDD	NN	B-NP	O	
)	)	)	O	O	
induction	induction	NN	B-NP	O	
(	(	(	O	O	
fourfold	fourfold	JJ	B-NP	O	
stimulation	stimulation	NN	I-NP	O	
)	)	)	O	O	
.	.	.	O	O	
It	It	PRP	B-NP	O	
was	be	VBD	B-VP	O	
found	find	VBN	I-VP	O	
that	that	IN	B-SBAR	O	
0	0	CD	B-NP	O	
.	.	.	O	O	
1	1	CD	B-NP	O	
microM	microM	NN	I-NP	O	
1EP	1EP	NN	I-NP	O	
and	and	CC	O	O	
1PP	1PP	NN	B-NP	O	
maximally	maximally	RB	B-ADVP	O	
induce	induce	VBP	B-VP	O	
CYP1B1	CYP1B1	NN	B-NP	B-protein	Mention 59	
and	and	CC	I-NP	O	
CYP1A1	CYP1A1	NN	I-NP	B-RNA	
mRNA	mRNA	NN	I-NP	I-RNA	
levels	level	NNS	I-NP	O	
in	in	IN	B-PP	O	
10T1/2	10T1/2	NN	B-NP	O	
and	and	CC	I-NP	O	
Hepa	Hepa	NN	I-NP	B-cell_line	
cells	cell	NNS	I-NP	I-cell_line	
,	,	,	O	O	
respectively	respectively	RB	B-ADVP	O	
,	,	,	O	O	
after	after	IN	B-PP	O	
6	6	CD	B-NP	O	
h	h	NN	I-NP	O	
.	.	.	O	O	
1-Ethylpyrene	1-Ethylpyrene	NN	B-NP	O	Mention 60	
(	(	(	O	O	
EtP	EtP	NN	B-NP	B-protein	Mention 61	
)	)	)	O	O	
,	,	,	O	O	
which	which	WDT	B-NP	O	
lacks	lack	VBZ	B-VP	O	
the	the	DT	B-NP	O	
activatable	activatable	JJ	I-NP	O	
acetylene	acetylene	NN	I-NP	O	
moiety	moiety	NN	I-NP	O	
,	,	,	O	O	
was	be	VBD	B-VP	O	
far	far	RB	B-ADJP	O	
less	less	RBR	I-ADJP	O	
effective	effective	JJ	I-ADJP	O	
as	as	IN	B-PP	O	
an	an	DT	B-NP	O	
inhibitor	inhibitor	NN	I-NP	O	
and	and	CC	B-PP	O	
as	as	IN	B-PP	O	
an	an	DT	B-NP	O	
inducer	inducer	NN	I-NP	O	
.	.	.	O	O	
AhR	AhR	NN	B-NP	B-protein	
activation	activation	NN	I-NP	O	
is	be	VBZ	B-VP	O	
essential	essential	JJ	B-ADJP	O	
for	for	IN	B-PP	O	
1EP	1EP	NN	B-NP	O	
induction	induction	NN	I-NP	O	
as	as	IN	B-SBAR	O	
evidenced	evidence	VBN	B-VP	O	
by	by	IN	B-PP	O	
the	the	DT	B-NP	O	
use	use	NN	I-NP	O	
of	of	IN	B-PP	O	
AhR	AhR	NN	B-NP	B-protein	
antagonists	antagonist	NNS	I-NP	O	
and	and	CC	O	O	
AhR-deficient	AhR-deficient	JJ	B-NP	O	
MEFs	MEF	NNS	I-NP	O	
and	and	CC	O	O	
absence	absence	NN	B-NP	O	
of	of	IN	B-PP	O	
induction	induction	NN	B-NP	O	
following	follow	VBG	B-PP	O	
inhibition	inhibition	NN	B-NP	O	
of	of	IN	B-PP	O	
DMBA	DMBA	NN	B-NP	O	Mention 62	
metabolism	metabolism	NN	I-NP	O	
with	with	IN	B-PP	O	
carbon	carbon	NN	B-NP	O	Mention 63	
monoxide	monoxide	NN	I-NP	O	
(	(	(	O	O	
CO	CO	NN	B-NP	O	Mention 64	
)	)	)	O	O	
.	.	.	O	O	
Inhibition	Inhibition	NN	B-NP	O	
of	of	IN	B-PP	O	
CYP1B1	CYP1B1	NN	B-NP	B-protein	Mention 65	
was	be	VBD	B-VP	O	
linked	link	VBN	I-VP	O	
to	to	TO	B-PP	O	
enhanced	enhance	VBN	B-NP	O	
AhR	AhR	NN	I-NP	B-protein	
activation	activation	NN	I-NP	O	
even	even	RB	B-ADVP	O	
at	at	IN	B-PP	O	
early	early	JJ	B-NP	O	
stages	stage	NNS	I-NP	O	
prior	prior	JJ	B-ADJP	O	
to	to	TO	B-PP	O	
significant	significant	JJ	B-NP	O	
ligand	ligand	NN	I-NP	O	
depletion	depletion	NN	I-NP	O	
.	.	.	O	O	
1EP	1EP	NN	B-NP	O	
and	and	CC	I-NP	O	
EtP	EtP	NN	I-NP	B-protein	
were	be	VBD	B-VP	O	
similarly	similarly	RB	B-ADJP	O	
effective	effective	JJ	I-ADJP	O	
in	in	IN	B-PP	O	
stimulating	stimulate	VBG	B-VP	O	
AhR	AhR	NN	B-NP	B-protein	
nuclear	nuclear	JJ	I-NP	O	
translocation	translocation	NN	I-NP	O	
,	,	,	O	O	
though	though	IN	B-SBAR	O	
5-10	5-10	CD	B-NP	O	
times	time	NNS	I-NP	O	
slower	slow	JJR	I-NP	O	
compared	compare	VBN	B-PP	O	
with	with	IN	B-PP	O	
TCDD	TCDD	NN	B-NP	O	
,	,	,	O	O	
and	and	CC	O	O	
produced	produce	VBD	B-VP	O	
no	no	DT	B-NP	O	
significant	significant	JJ	I-NP	O	
down-regulation	down-regulation	NN	I-NP	O	
of	of	IN	B-PP	O	
the	the	DT	B-NP	O	
AhR	AhR	NN	I-NP	B-protein	
.	.	.	O	O	
TCDD	TCDD	NN	B-NP	B-protein	
activated	activate	VBD	B-VP	I-protein	
AhR/Arnt	AhR/Arnt	NN	B-NP	I-protein	
complex	complex	NN	I-NP	I-protein	
formation	formation	NN	I-NP	O	
with	with	IN	B-PP	O	
an	an	DT	B-NP	O	
oligonucleotide	oligonucleotide	NN	I-NP	B-DNA	
xenobiotic	xenobiotic	JJ	I-NP	I-DNA	
response	response	NN	I-NP	I-DNA	
element	element	NN	I-NP	I-DNA	
far	far	RB	B-ADVP	O	
more	more	RBR	I-ADVP	O	
extensively	extensively	RB	I-ADVP	O	
than	than	IN	B-PP	O	
1EP	1EP	NN	B-NP	O	
or	or	CC	I-NP	O	
EtP	EtP	NN	I-NP	B-protein	
,	,	,	O	O	
even	even	RB	B-PP	O	
at	at	IN	I-PP	O	
concentrations	concentration	NNS	B-NP	O	
of	of	IN	B-PP	O	
1EP	1EP	NN	B-NP	O	
that	that	WDT	B-NP	O	
increased	increase	VBD	B-VP	O	
CYP1B1	CYP1B1	NN	B-NP	B-RNA	
mRNA	mRNA	NN	I-NP	I-RNA	
to	to	TO	B-PP	O	
similar	similar	JJ	B-NP	O	
levels	level	NNS	I-NP	O	
.	.	.	O	O	
CO	CO	NN	B-NP	O	
did	do	VBD	B-VP	O	
not	not	RB	I-VP	O	
influence	influence	VB	I-VP	O	
these	these	DT	B-NP	O	
responses	response	NNS	I-NP	O	
to	to	TO	B-PP	O	
EtP	EtP	NN	B-NP	B-protein	
,	,	,	O	O	
event	event	NN	B-NP	O	
hough	hough	NN	I-NP	O	
CO	CO	NN	I-NP	O	
treatment	treatment	NN	I-NP	O	
potentiated	potentiate	VBD	B-VP	O	
EtP	EtP	NN	B-NP	B-protein	
induction	induction	NN	I-NP	O	
of	of	IN	B-PP	O	
CYP1B1	CYP1B1	NN	B-NP	B-RNA	
mRNA	mRNA	NN	I-NP	I-RNA	
.	.	.	O	O	
These	These	DT	B-NP	O	
differences	difference	NNS	I-NP	O	
suggest	suggest	VBP	B-VP	O	
a	a	DT	B-NP	O	
fundamental	fundamental	JJ	I-NP	O	
difference	difference	NN	I-NP	O	
between	between	IN	B-PP	O	
PAH/AhR	PAH/AhR	NN	B-NP	B-protein	
and	and	CC	I-NP	O	
TCDD/AhR	TCDD/AhR	NN	I-NP	B-protein	
complexes	complex	NNS	I-NP	I-protein	
where	where	WRB	B-ADVP	O	
CYP1B1	CYP1B1	NN	B-NP	B-protein	
metabolic	metabolic	JJ	I-NP	O	
activity	activity	NN	I-NP	O	
regulates	regulate	VBZ	B-VP	O	
the	the	DT	B-NP	O	
potency	potency	NN	I-NP	O	
,	,	,	O	O	
rather	rather	RB	B-PP	O	
than	than	IN	I-PP	O	
the	the	DT	B-NP	O	
formation	formation	NN	I-NP	O	
of	of	IN	B-PP	O	
the	the	DT	B-NP	O	
AhR/Arnt	AhR/Arnt	NN	I-NP	B-protein	
complex	complex	NN	I-NP	I-protein	
.	.	.	O	O	
Copyright	Copyright	NN	B-NP	O	
1999	1999	CD	I-NP	O	
Academic	Academic	NNP	I-NP	O	
Press	Press	NNP	I-NP	O	
.	.	.	O	O	
